Abstract
Virus neutralization test (VNT) and liquid phase blocking ELISA (LPBE) are accepted tests for screening and as in vitro alternativ to challenge in FMD vaccine potency testing. To replace VNT by LPBE for the screening of cattle, the optimized tests need to be first evaluated for their diagnostic performances. To replace it with LPBE in the absence of protection data, the interrelationship between VNT and LPBE have to be established to find out LPBE cut‑off titer corresponding to the currently used VNT titers. Accordingly, VNT and LPBE were carried out using known negative (n = 306) and positive samples [Serotype O (n = 43), A (n = 14) and Asia1 (n = 11)], for the initial screening. The cut‑off of < 1.5 log10 LPBE was comparable with that of < 1.2 log10 VNT titer for screening. LPBE was comparable to VNT in terms of specificity, sensitivity as shown by ROC curve and least varying (coefficient of variation 7.73% in LPBE vs 24.19% in VNT). Based on linear regression model using 471 bovine sera, the predicted LPBE titers corresponding to the currently used log 10 VNT titers of 1.65, 1.5 and 1.5, were 2.24, 1.87 and 2.00 for O, A and Asia1, respectively. These LPBE titers hence can be used as cut‑off titers for classifying cattle as protected or not protected until correlation based on in vivo challenge between protection and antibody titer is established.
References
Department of Animal Husbandy, Dairing & Fisheries (DADF). 2018. Annual Report 2017-2018. Ministry of Agriculture and Farmers Welfare, Government of India.
Fluss R., Faraggi D. & Reiser B. 2005. Estimation of the Youden Index and its associated cutoff point. Biometrical J, 47, 458–472. doi:10.1002/bimj.200410135
Grubman M.J. & Baxt B. 2004. Foot-and-mouth disease. Clin Microbiol Rev, 17, 465–493.
Hamblin C., Barnett I.T. & Crowther J.R. 1986. A new enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus. II. Application. J Immunol Methods, 93, 123–129.
Hamblin C., Barnett I.T.R.& Hedger R.S., 1986. A new enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus I. Development and method of ELISA. J Immunol Methods, 93, 115–121. doi:10.1016/0022-1759(86)90441-2
Hosamani M., Basagoudanavar S.H., Tamil Selvan R.P., Das V., Ngangom P., Sreenivasa B.P., Hegde R. & Venkataramanan R. 2015. A multi-species indirect ELISA for detection of non-structural protein 3ABC specific antibodies to foot-and-mouth disease virus. Arch Virol, 160, 937–944. doi:10.1007/s00705-015-2339-9
Indian Pharmacopoeia Commission (IPC). 2018. Indian Pharmacopoeia . 8 ed. https://www.indianpharmacopoeia.in/
Jacobson R.H. 1998. Validation of serological assays for diagnosis of infectious diseases. Rev Sci Tech, 17, 469–526.
King D.& Henstock M. 2015. OIE / FAO Foot-and-Mouth Disease Reference Laboratory Network Annual Report 2015. The Pirbright Institute, UK.
Maradei E., La Torre J., Robiolo B., Esteves J., Seki C., Pedemonte A., Iglesias M., D’Aloia R.& Mattion N. 2008. Updating of the correlation between lpELISA titers and protection from virus challenge for the assessment of the potency of polyvalent aphtovirus vaccines in Argentina. Vaccine, 26, 6577–6586. doi:10.1016/j.vaccine.2008.09.033
Mattion N., Goris N., Willems T., Robiolo B., Maradei E., Beascoechea C.P., Perez A., Smitsaart E., Fondevila N., Palma E., De Clercq K.& La Torre J. 2009. Some guidelines for determining foot-and-mouth disease vaccine strain matching by serology. Vaccine, 27, 741–747. doi:10.1016/j.vaccine.2008.11.026
McCullough K.C., Bruckner L., Schaffner R., Fraefel W., Muller H.K.& Kihm U. 1992. Relationship between the anti-FMD virus antibody reaction as measured by different assays, and protection in vivo against challenge infection. Vet Microbiol, 30, 99–112. doi:10.1016/0378-1135(92)90106-4
Periolo O.H., Seki C., Grigera P.R., Robiolo B., Fernández G., Maradei E., D’Aloia R.& La Torre J.L. 1993. Large-scale use of liquid-phase blocking sandwich ELISA for the evaluation of protective immunity against aphthovirus in cattle vaccinated with oil-adjuvanted vaccines in Argentina. Vaccine, 11, 754–760. doi:10.1016/0264-410X(93)90261-U
Project Directorate on Foot and Mouth Disease (PDFMD). 2016. Annual Report 2011-2016. Mukteswar, Nainital (Dt),Uttarakhand, India
R Development Core Team (2014) R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. R Foundation for Statistical Computing, Vienna.
Robin X., Turck N., Hainard A., Tiberti N., Lisacek F., Sanchez J.-C.& Müller M. 2011. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics, 12, 77. doi:10.1186/1471-2105-12-77
Smitsaart E.N., Zanelli M., Rivera I., Fondevila N., Compaired D., Maradei E., Bianchi T., O’Donnell V.& Schudel A.A. 1998. Assessment using ELISA of the herd immunity levels induced in cattle by foot-and-mouth disease oil vaccines. Prev Vet Med, 33, 283–296. doi:10.1016/S0167-5877(97)00014-7
Van Maanen C.& Terpstra C. 1989. Comparison of a liquid-phase blocking sandwich ELISA and a serum neutralization test to evaluate immunity in potency tests of foot-and-mouth disease vaccines. J Immunol Methods, 124, 111–119. doi:10.1016/0022-1759(89)90192-0
Wickham H. 2009. Ggplot2: Elegant Graphics for Data Analysis. 2 ed. Springer-Verlag, New York.
Willems T., Lefebvre D.J., Goris N., Diev V.I., Kremenchugskaya,S.R., Paul G., Haas B.& De Clercq K. 2012. Characteristics of serology-based vaccine potency models for foot-and-mouth disease virus. Vaccine, 30, 5849–5855. doi:10.1016/j.vaccine.2012.07.015
World Organisation for Animal Health ( OIE). 2018. Foot and Mouth Disease. Version adopted by the World Assembly of Delegates of the OIE in May 2017. https://www.oie.int/app/uploads/2021/03/a-reso-2018.pdf